Long Focus Capital Management LLC Purchases New Position in MeiraGTx Holdings plc (NASDAQ:MGTX)

Long Focus Capital Management LLC acquired a new position in shares of MeiraGTx Holdings plc (NASDAQ:MGTX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 189,745 shares of the company's stock, valued at approximately $1,156,000. Long Focus Capital Management LLC owned approximately 0.24% of MeiraGTx at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the company. Summit Investment Advisors Inc. raised its holdings in MeiraGTx by 106.7% during the fourth quarter. Summit Investment Advisors Inc. now owns 4,871 shares of the company's stock worth $30,000 after purchasing an additional 2,515 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in shares of MeiraGTx by 68.1% during the 4th quarter. Tower Research Capital LLC TRC now owns 4,975 shares of the company's stock worth $30,000 after buying an additional 2,016 shares during the last quarter. Polymer Capital Management US LLC acquired a new stake in MeiraGTx in the 4th quarter valued at about $88,000. China Universal Asset Management Co. Ltd. increased its holdings in MeiraGTx by 11.3% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 16,571 shares of the company's stock valued at $101,000 after acquiring an additional 1,685 shares in the last quarter. Finally, PUREfi Wealth LLC acquired a new position in MeiraGTx during the fourth quarter worth about $122,000. Hedge funds and other institutional investors own 67.48% of the company's stock.

MeiraGTx Trading Down 1.2 %

Shares of MGTX stock traded down $0.08 during mid-day trading on Monday, hitting $6.62. 180,608 shares of the company's stock were exchanged, compared to its average volume of 516,586. The stock has a 50-day simple moving average of $6.54 and a two-hundred day simple moving average of $6.32. MeiraGTx Holdings plc has a fifty-two week low of $3.85 and a fifty-two week high of $8.75. The stock has a market cap of $522.02 million, a price-to-earnings ratio of -5.47, a PEG ratio of 0.37 and a beta of 1.21. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.86.

MeiraGTx (NASDAQ:MGTX - Get Free Report) last posted its quarterly earnings data on Thursday, March 13th. The company reported ($0.50) EPS for the quarter, missing analysts' consensus estimates of ($0.48) by ($0.02). MeiraGTx had a negative net margin of 633.05% and a negative return on equity of 146.38%. The company had revenue of $21.39 million for the quarter, compared to analyst estimates of $1.50 million. Equities analysts expect that MeiraGTx Holdings plc will post -1.48 EPS for the current fiscal year.

Insider Activity

In other MeiraGTx news, CFO Richard Giroux sold 24,000 shares of the business's stock in a transaction dated Tuesday, April 22nd. The stock was sold at an average price of $6.00, for a total transaction of $144,000.00. Following the completion of the sale, the chief financial officer now owns 882,494 shares of the company's stock, valued at approximately $5,294,964. The trade was a 2.65 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Alexandria Forbes sold 47,500 shares of the company's stock in a transaction dated Tuesday, April 8th. The stock was sold at an average price of $5.34, for a total value of $253,650.00. Following the sale, the chief executive officer now owns 1,408,983 shares of the company's stock, valued at $7,523,969.22. This represents a 3.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 8.40% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on MGTX. Chardan Capital reissued a "buy" rating and set a $36.00 price objective on shares of MeiraGTx in a research note on Monday, February 24th. Royal Bank of Canada boosted their price target on MeiraGTx from $11.00 to $13.00 and gave the stock an "outperform" rating in a report on Monday, March 17th.

About MeiraGTx

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.